Close
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

23andMe scraps health analysis while it fights with the FDA

X
Your article was successfully shared with the contacts you provided.

While the Food and Drug Administration sorts out the ethics of 23andMe’s consumer DNA tests, customers who sent tests in after the Nov. 22 warning will receive a scaled back report of their results. Customers can see what their DNA reveals about their ancestral origins but will not learn what health traits are associated with their genes or what diseases they may be prone to. The FDA’s warning is not over people getting their DNA, but the interpretation of the results.

More on this topic